Cardiovascular Drugs and Therapy

Oxidized Low Density Lipoproteins-Do We Know Enough About Them?
pp. 367-377(11)
Authors: Jiang, Xueting; Yang, Zhaohui; Chandrakala, Aluganti; Pressley, Dawn; Parthasarathy, Sampath

The Discovery of LOX-1, its Ligands and Clinical Significance
pp. 379-391(13)
Authors: Yoshimoto, Ryo; Fujita, Yoshiko; Kakino, Akemi; Iwamoto, Shin; Takaya, Tomohide; Sawamura, Tatsuya

LOX-1 Transcription
pp. 393-400(8)
Authors: Hermonat, Paul; Zhu, Hongqing; Cao, Maohua; Mehta, Jawahar

LOX-1 and Angiotensin Receptors, and Their Interplay
pp. 401-417(17)
Authors: Wang, Xianwei; Phillips, M.; Mehta, Jawahar

Oxidized LDL, LOX-1 and Atherosclerosis
pp. 419-429(11)
Authors: Mitra, Sona; Goyal, Tanu; Mehta, Jawahar

LOX-1: A Critical Player in the Genesis and Progression of Myocardial Ischemia
pp. 431-440(10)
Authors: Lü, Jingjun; Mehta, Jawahar

Novel Concepts in the Genesis of Hypertension: Role of LOX-1
pp. 441-449(9)
Authors: Luo, Ping; Yan, Meiling; Frohlich, Edward; Mehta, Jawahar; Hu, Changping

LOX-1, Oxidative Stress and Inflammation: A Novel Mechanism for Diabetic Cardiovascular Complications
pp. 451-459(9)
Authors: Yan, Meiling; Mehta, Jawahar; Zhang, Weifang; Hu, Changping

Angiogenesis is a Link Between Atherosclerosis and Tumorigenesis: Role of LOX-1
pp. 461-468(8)
Authors: Jiang, Junlin; Yan, Meiling; Mehta, Jawahar; Hu, Changping

LOX-1 and Obesity
pp. 469-476(8)
Authors: Yan, Meiling; Mehta, Jawahar; Hu, Changping

Do Atherosclerosis and Obesity-Associated Susceptibility to Cancer Share Causative Link to oxLDL and LOX-1?
pp. 477-487(11)
Authors: Khaidakov, Magomed; Mehta, Jawahar

LOX-1/LOXIN: The Yin/Yang of Atheroscleorosis
pp. 489-494(6)
Authors: Mango, Ruggiero; Predazzi, Irene; Romeo, Francesco; Novelli, Giuseppe

LOX-1: A New Target for Therapy for Cardiovascular Diseases
pp. 495-500(6)
Authors: Mehta, Jawahar; Khaidakov, Magomed; Hermonat, Paul; Mitra, Sona; Wang, Xianwei; Novelli, Guiseppe; Sawamura, Tatsuya